Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
31,526
Total Claims
$703K
Drug Cost
444
Beneficiaries
$1,584
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 16,767 Hospitalist providers
-36%
Opioid rate vs peers
1.9% vs 3.0% avg
+271%
Cost per patient vs peers
$1,584 vs $427 avg
+82%
Brand preference vs peers
9.5% vs 5.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.9%
Opioid Rate
608
Opioid Claims
$10K
Opioid Cost
5.3%
Long-Acting Rate
Brand vs Generic
Brand: 2,984 claims · $412K
Generic: 28,363 claims · $281K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 820 | $145K |
| Insulin Glargine,hum.Rec.Anlog | 141 | $24K |
| Abiraterone Acetate | 11 | $22K |
| Insulin Aspart | 137 | $20K |
| Dextromethorphan Hbr/Quinidine | 26 | $20K |
| Dapagliflozin Propanediol | 96 | $18K |
| Empagliflozin | 68 | $16K |
| Memantine Hcl | 642 | $13K |
| Atorvastatin Calcium | 1,926 | $11K |
| Sitagliptin Phosphate | 76 | $10K |
| Cyclosporine | 25 | $9,820 |
| Insulin Lispro | 52 | $9,554 |
| Gabapentin | 1,449 | $9,454 |
| Divalproex Sodium | 566 | $9,070 |
| Sucralfate | 59 | $8,421 |
Prescribing Profile
Patient Profile
77
Avg Age
66%
Female
2.41
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About